Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis

European Respiratory Journal

Volumn 24, Issue 4, 2004, Pages 631-637

  Aaron, S D ^a,b   Kottachchi, D ^a   Ferris, W J ^a   Vandemheen, K L ^a   St Denis, M L ^a   Doucette, S P ^a   Saginur, R ^a   Chan, F T ^a   Ramotar, K ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Bronchoscopy; Cystic fibrosis; Microbiology; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZITHROMYCIN; BRONCHODILATING AGENT; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; MEROPENEM; PANCREAS ENZYME; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN; VITAMIN;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BIOFILM; BRONCHOSCOPY; BRONCHUS BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE TECHNIQUE; CYSTIC FIBROSIS; FEMALE; GENOTYPE; GRAM NEGATIVE INFECTION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG LAVAGE; MALE; NONHUMAN; PLANKTON; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT MUCOSA; SPUTUM ANALYSIS;

ADULT; BIOFILMS; BIOPSY; BRONCHI; BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; CHRONIC DISEASE; CYSTIC FIBROSIS; DRUG RESISTANCE, MICROBIAL; FEMALE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM;

EID: 6444244008     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00049104     Document Type: Article

References (29)

1. Fick RB Jr. Pathogenesis of the pseudomonas lung lesion in cystic fibrosis. Chest 1989; 96: 158-164.
2. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A Component of innate immunity prevents baceterial biofilm development. Nature 2002; 417: 552-555.
3. Drenkard E, Ausubel FM. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 2002; 416: 740-743.
4. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000; 407: 762-764.
5. Costerton JW. Introduction to biofilm. Int J Antimicrob Agents 1999; 11: 217-221.
6. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-1322.
7. Aaron SD, Ferris W, Ramotar K, Vandemheen K, Chan F, Saginur R. Single and combination antibiotic susceptibilities of planktonic, adherent and biofilm-grown Pseudomonas aeruginosa cultured from CF sputum. J Clin Microbiology 2002; 40: 4172-4179.
8. Kahn FW, Jones JM. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis 1987; 155: 862-869.
9. Thorpe JE, Baughman RP, Frame PT, Wesseler TA, Staneck JL. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis 1987; 155: 855-861.
10. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150: 448-454.
11. Baughman RP, Keeton DA, Perez C, Wilmott RW. Use of bronchoalveolar lavage semiquantitative cultures in cystic fibrosis. Am J Respir Crit Care Med 1997; 156: 286-291.
12. Chastre J, Fagon J-Y, Bornet-Lesco M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995; 152: 231-240.
13. Chastre J, Viau F, Brun P, et al. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am Rev Respir Dis 1984; 130: 924-929.
14. Higuchi JH, Coalson JJ, Johanson WG Jr. Bacteriologic diagnosis of nosocial pneumonia in primates. Usefulness of the protected specimen brush. Am Rev Respir Dis 1982; 125: 53-57.
15. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiology Rev 1991; 4: 35-51.
16. Miller MB, Gilligan PH. Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol 2003; 41: 4009-4015.
17. Aaron SD, Ramotar K, Ferris W, et al. Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa. Am J Respir Crit Care Med 2004; 169: 811-815.
18. Tenover FC, Arbeit RD, Goering RV. Interpreting chromosomal DNA restriction patterns produced by pulse-field gel electrophoresis: criteria for bacterial stain typing. J Clin Microbiol 1995; 33: 2233-2239.
19. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standards. National Committee for Clinical Laboratory Standards (NCCLS). Wayne PA, NCCLS, 2003.
20. Aaron SD, Ferris W, Henry DA, Speert DP, MacDonald NE. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med 2000; 161: 1206-1212.
21. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 1771-1776.
22. Breitenstein S, Walter S, Bobhammer J, Romling U, Tummler B. Direct sputum analysis of Pseudomonas aeruginosa macrorestriction fragment genotypes in patients with cystic fibrosis. Med Microbiol Immunol 1997; 186: 93-99.
23. Struelens MJ, Schwam V, Delpano A, Baran D. Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. J Clin Microbiol 1993; 31: 2320-2326.
24. Cheng K, Smyth RL, Govan JRW, et al. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996; 348: 639-642.
25. Jones AM, Govan JRW, Doherty CJ, et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001; 358: 557-558.
26. McCullum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet 2001; 358: 558-560.
27. Anthony M, Rose B, Beard-Pegler M, et al. Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J Clin Microbiol 2002; 40: 2772-2778.
28. Armstrong DS, Nixon GM, Carzino R, et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Resp Crit Care Med 2002; 166: 983-987.
29. Jones AM, Webb AK, Govan JR, Hart CA, Walshaw MJ. Pseudomonas aeruginosa cross-contamination in cystic fibrosis. Lancet 2002; 359: 527-528.